Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation

Research output: Contribution to journalLetter

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)187-188
Number of pages2
JournalTransfusion Medicine
Volume24
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Pure Red-Cell Aplasia
Boronic Acids
Pyrazines
Blood Group Incompatibility
Hematopoietic Stem Cell Transplantation
Subcutaneous Injections
Antineoplastic Agents
Bortezomib

Cite this

@article{35df98ef35094a3e9a4fc70ecfb70979,
title = "Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation",
author = "F. Khan and Linden, {Michael A} and Zantek, {Nicole D} and Vercellotti, {Gregory M}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/tme.12121",
language = "English (US)",
volume = "24",
pages = "187--188",
journal = "Transfusion Medicine",
issn = "0958-7578",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation

AU - Khan, F.

AU - Linden, Michael A

AU - Zantek, Nicole D

AU - Vercellotti, Gregory M

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84901489095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901489095&partnerID=8YFLogxK

U2 - 10.1111/tme.12121

DO - 10.1111/tme.12121

M3 - Letter

VL - 24

SP - 187

EP - 188

JO - Transfusion Medicine

JF - Transfusion Medicine

SN - 0958-7578

IS - 3

ER -